The how and why of assessing frailty syndrome in cardiac surgery

Marta Wleklik, Michał Czapla, Quin Denfeld, Roman Przybylski, Krzysztof Reczuch, Izabella Uchmanowicz

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Frailty syndrome (FS) is one of the most important variables that have a proven impact on the increased risk of morbidity and mortality in cardiac surgery. However, FS assessment is not routinely incorporated into daily clinical practice or included in commonly used risk assessment models. The inclusion of FS in perioperative risk prediction models in cardiac surgery would not only allow for a more accurate assessment but could also assist in the selection of an appropriate treatment strategy while favoring the appropriate use of clinical resources. The identification of FS in the qualification process must not be seen as an absolute contraindication to cardiac surgery but as an opportunity to adequately prepare the patient for the procedure. However, the literature is heterogeneous in terms of the selection of an appropriate tool for identifying FS. Selected tools commonly used in the assessment of FS in patients with cardiovascular disease, including those of greatest relevance in cardiac surgery, are presented in this editorial.

Original languageEnglish (US)
Pages (from-to)1061-1064
Number of pages4
JournalAdvances in Clinical and Experimental Medicine
Issue number10
StatePublished - Oct 2022


  • cardiac surgery
  • frailty syndrome
  • older adult
  • perioperative risk

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine (miscellaneous)
  • Reviews and References, Medical
  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics(clinical)
  • Pharmacology (medical)


Dive into the research topics of 'The how and why of assessing frailty syndrome in cardiac surgery'. Together they form a unique fingerprint.

Cite this